AI Summary Hepatitis D testing is for people who have or may have hepatitis B, because the hepatitis D virus cannot infect anyone without it. A total anti-HDV antibody test comes first. If it is positive, an HDV RNA test shows whether the virus is active. Hepatitis D can progress quickly to cirrhosis or liver failure. No treatment reliably cures it, so care focuses on monitoring, and the hepatitis B vaccine prevents both infections.
Source: www.liverdirectory.com
Medically reviewed
Hepatitis D testing looks for antibodies against the hepatitis D virus (HDV), and confirms active infection with an HDV RNA test. Because HDV is an incomplete virus that can only infect people who also carry hepatitis B, doctors order this test in people who already have hepatitis B — not as a general screening test.
Testing starts with a total anti-HDV antibody test. If that result is positive, a doctor follows up with an HDV RNA test to confirm whether the virus is currently active in the blood.
Liver Health AI Assistant
Ask Aimy
Aimy answers from LiverDirectory’s reviewed health information — helping patients make sense of liver-health terms, prepare for specialist visits, and explore what to look up next.
ABOUT THIS TEST
Hepatitis D is caused by the hepatitis D virus (HDV), sometimes called delta hepatitis. HDV is an "incomplete" virus — it cannot infect liver cells or reproduce on its own. It needs the hepatitis B virus (HBV) to be present at the same time, so hepatitis D only ever occurs in someone who also has hepatitis B.
Because of that relationship, hepatitis D testing is not a stand-alone screening test. Doctors consider it for people known to have hepatitis B, or for people who develop unusually severe liver symptoms during a hepatitis B infection. The test looks first for total anti-HDV antibodies, which show that the immune system has responded to the virus. A positive antibody result is then confirmed with an HDV RNA test, which detects the virus's genetic material and shows whether HDV is currently active.
Hepatitis D testing is different from a liver function test (LFT) panel. LFTs, such as ALT, AST, and bilirubin, measure how the liver is working and can flag inflammation or injury, but they cannot identify the cause. Hepatitis D testing looks specifically for evidence of HDV, which is what confirms it as a cause of liver inflammation in someone with hepatitis B.
WHO SHOULD GET TESTED
Because HDV can only infect someone who also carries hepatitis B, doctors most often order hepatitis D testing in people with a known hepatitis B diagnosis, especially if liver inflammation seems worse than expected for hepatitis B alone.
A hepatitis B patient who develops sudden, severe symptoms — such as jaundice, marked fatigue, or signs of liver failure — may be tested for hepatitis D, since a new HDV infection on top of hepatitis B can cause more aggressive disease.
People who inject drugs, have hemophilia, or have had other percutaneous or mucosal exposure to infected blood are at higher risk for hepatitis D and may be tested if they also have hepatitis B.
Some people with chronic hepatitis B are tested for hepatitis D periodically, particularly if their liver disease is progressing faster than expected, according to LiverDirectory's Hepatitis D guide.
READING YOUR LAB RESULTS
A negative result means no antibodies against HDV were found. In someone with hepatitis B and no HDV exposure, this is the expected result and no further HDV testing is usually needed.
A positive result means the immune system has been exposed to HDV at some point. Because this test cannot tell a current infection from a past one, a positive result is followed by an HDV RNA test to check whether the virus is currently active.
A detected result means HDV is currently active and multiplying in the blood. This confirms an active hepatitis D infection, which needs ongoing care from a liver specialist.
A not-detected result with a positive antibody test suggests a past HDV exposure that is not currently active. A doctor may still recommend monitoring, since HDV activity can fluctuate over time.
COINFECTION VS. SUPERINFECTION
Hepatitis D cannot exist without hepatitis B, so understanding the relationship between the two viruses matters for interpreting a hepatitis D test.
Coinfection happens when a person is infected with hepatitis B and hepatitis D at the same time. This can cause a severe acute illness, but in some people the immune system clears both viruses.
Superinfection happens when someone who already has chronic hepatitis B is newly infected with hepatitis D. This pattern more often leads to chronic hepatitis D and tends to progress faster than hepatitis B alone.
Hepatitis D is considered the most aggressive form of viral hepatitis. Up to 5% of coinfections and up to 20% of chronic hepatitis B and D co-infections lead to fulminant hepatitis, a rapid, life-threatening form of liver failure with a mortality rate around 80%. Overall, the mortality rate for hepatitis D is 2% to 20%, about ten times that of hepatitis B alone. Because hepatitis D speeds up liver damage, a positive hepatitis D test in someone with hepatitis B usually leads to closer monitoring and referral to a liver specialist.
MANAGEMENT & PREVENTION
There is no specific antiviral treatment that reliably cures hepatitis D. Interferon therapy can help push the virus into remission, but many people remain positive for HDV RNA afterward. Because of this, care focuses on close monitoring for liver damage and, for advanced or fulminant disease, evaluation for liver transplant.
Hepatitis D prevention works through hepatitis B prevention. There is no vaccine for HDV itself, but the hepatitis B vaccine prevents hepatitis B infection and, by extension, prevents hepatitis D, since HDV cannot infect someone without hepatitis B.
People with chronic hepatitis B should avoid behaviors that raise the risk of a new bloodborne infection, such as sharing needles, and should let their doctor know about any percutaneous or mucosal exposure to someone else's blood so hepatitis D testing can be considered promptly.
A balanced, liver-friendly diet supports your liver, helps manage weight and blood sugar, and lowers the risk of other health problems during long-term follow-up.
Explore Liver DietThe Amsety Bar is a liver-friendly snack or meal replacement that can make it easier to eat well on busy days.
Shop Amsety Bars
Common Questions
No. Hepatitis D can only infect someone who is already infected with hepatitis B, or who catches both viruses at the same time. HDV is an "incomplete" virus, which means it needs hepatitis B to manifest and reproduce. If you do not have hepatitis B, you cannot have hepatitis D, and a hepatitis D test is not part of routine screening.
Diagnosis takes two blood tests, in order. First, a total anti-HDV antibody test shows whether your immune system has responded to the virus. A positive antibody result cannot tell a current infection from a past one, so a doctor then orders an HDV RNA test. If HDV RNA is detected, the virus is actively multiplying. If it stays detectable for more than six months, the infection is considered chronic.
The difference is timing. Coinfection means you catch hepatitis B and hepatitis D at the same time. It can cause a severe acute illness, but some people clear both viruses. Superinfection means hepatitis D infects someone who already has chronic hepatitis B. This pattern more often leads to chronic hepatitis D and faster liver damage, including a higher risk of cirrhosis and liver-related death. Your doctor uses your results and history to tell which one applies.
No, there is no vaccine made for hepatitis D. The hepatitis B vaccine is the main protection, though. It prevents hepatitis B infection, and HDV cannot infect someone who does not have hepatitis B, so the vaccine prevents both infections. People who carry hepatitis B should also learn how it spreads, including risky behaviors and mother-to-child transmission, to avoid passing it on.
People who already have hepatitis B are the only ones at risk. Hepatitis D spreads mainly through contact with infected blood, either through the skin (percutaneous) or through mucous membranes. In the United States it is relatively uncommon, except among people who inject drugs and people with hemophilia. Doctors may also test people with chronic hepatitis B whose liver disease is progressing faster than expected. Talk with your doctor if you have hepatitis B and think you may have been exposed.
Medical disclaimer: LiverDirectory provides educational information and a directory of providers. It does not provide medical advice, diagnosis, or treatment. Always consult a licensed physician regarding any medical condition.
